Equinix enters into multiple advanced nuclear deals to power data centers
Big Tech's race to expand technologies like generative artificial intelligence, which requires warehouse-like data centers that can require city-sized amounts of electricity at a single site, is driving up global energy consumption and raising fears about depleted power supplies.
The voracious energy needs of data centers has led to a rising number of preliminary power deals to fuel data centers with advanced nuclear energy.
Small modular reactors and other next-generation energy is not yet commercially available in the U.S., the world's data center hub.
The Equinix announcement follows news that the U.S. Department of Energy earlier had selected an initial 11 projects for a pilot program seeking to develop high-tech test nuclear reactors with the aim of getting three of the projects operating in less than a year.
Equinix's deals with advanced nuclear providers would supply more than 1 gigawatt of electricity to the company's data centers.
Among the agreements, Equinix plans to procure 500 megawatts of energy from California-based Oklo's next-generation nuclear fission powerhouses. It also entered into a preorder agreement for 20 transportable microreactors from Radiant Nuclear, which is also based in California.
In Europe, Equinix's agreements to eventually purchase power from next-generation nuclear developers, ULC-Energy and Stellaria.
Equinix also entered into advanced fuel cell agreements with Bloom Energy, based in Silicon Valley.
The agreements are part of Equinix's long-term planning for electricity to use for its data centers, as opposed to a quick-fix solution, Raouf Abdel, Equinix's executive vice president of global operations, told Reuters.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
5 minutes ago
- The Independent
Faith-based activist groups celebrate after Costco bails on selling abortion pill
Costco has opted not to dispense abortion pills after receiving demands from activists on both sides of the issue — and faith-based groups are celebrating the move. Last year, New York City Comptroller Brad Lander urged the retail giant to get a certification to be able to dispense mifepristone — one drug in a two-drug regimen for medication abortions — at its pharmacies. The following month a religious coalition pleaded with Costco not to sell the termination pill. The FDA allows only certified prescribers to dispense mifepristone. Costco chose to forego pursuing this certification, the company said in a statement to Reuters emphasizing the decision was based on a lack of consumer demand. "Our position at this time not to sell mifepristone, which has not changed, is based on the lack of demand from our members and other patients, who we understand generally have the drug dispensed by their medical providers,' the company said. Bloomberg first reported Costco's decision. The Independent has reached out to Costco for more information about its decision. Representatives on both sides of the abortion debate have battled over Costco's position in the form of letters. Last July, Lander penned a letter to CEO Ron Vachris demanding the retailer 'immediately take the necessary steps to receive certification' to sell mifepristone, following in the steps of CVS and Walgreens. The comptroller also wrote letters to the leaders of Walmart, Kroger, Albertsons, and McKesson. 'By failing to become certified mifepristone dispensers, these pharmacy giants put both women's reproductive health care and investors' money at risk,' he said in a statement at the time. In August 2024, a coalition of religious activists wrote to Vachris, urging Costco to 'continue its current practice of not dispensing the abortion drug mifepristone.' The group argued that dispensing the drug will reduce demand for the diapers and formula that the store sells and worsen the 'the crisis of record low birth rates.' The letter also alleged the pill poses 'serious health risks.' The FDA first approved the drug in 2000 to end pregnancy through 10 weeks of gestation, but anti-abortion activists have recently challenged its safety and FDA approval. Last year, the Supreme Court unanimously ruled to preserve access to the crucial drug, as nearly two-thirds of all abortions in the U.S. — 63 percent — are medication abortions, according to the Guttmacher Institute. 'Costco's decision to refuse to dispense mifepristone is disappointing and short-sighted,' a spokesperson for Lander told The Independent in a statement. Failure to provide access to proven safe and FDA-approved medication under the guise of 'weak demand' risks isolating customers and undermines the company's credibility. Putting customer needs before political ideology must remain Costco's priority.' Faith-based activists have celebrated the decision. 'We applaud Costco for doing the right thing by its shareholders and resisting activist calls to sell abortion drugs,' Alliance Defending Freedom Legal Counsel Michael Ross said in a statement Thursday. 'They have nothing to gain and much to lose by becoming abortion dispensaries.' 'We have this momentum,' Tim Schwarzenberger, director of corporate engagement at Inspire Investing, the world's largest faith-based ETF provider, told Bloomberg. 'Now there is a chance to turn to some of the other retailers.' 'We are so grateful that Costco—a company that serves families, especially large ones—has decided to remain a wholesale store, not become an abortion facility,' Mary Szoch, director of the Center for Human Dignity at evangelical think-tank Family Research Council, said in a statement on X. 'What a win for America! Great job, @Costco!" CVS and Walgreens, which both dispense the drug, have stood by their decisions in the wake of Costco's announcement. 'We have a long history of supporting and advancing women's health and we remain focused on meeting their unique health needs. This includes providing access to safe, legal, and evidence-based reproductive health services,' CVS told The Independent in a statement, noting that the company fills prescriptions in states where it's legal. Walgreens declined to comment. Its website states: "The U.S. Supreme Court's ruling on mifepristone access allows Walgreens to continue to dispense mifepristone under the FDA guidelines.' The abortion landscape has been complicated after the fall of Roe v. Wade in 2022. In January 2023, the FDA removed some restrictions around accessing mifepristone and added the pharmacy certification. Individuals living in states that have banned the procedure cannot access the drug at pharmacies; 12 states have total abortion bans, according to Guttmacher Institute. The 2022 Supreme Court ruling overturning Roe has opened the door for abortion opponents to argue fresh legal challenges. Earlier this year, anti-abortion activists pushed a report by right-wing think tank Ethics and Public Policy Center claiming serious complications from mifepristone use were 22 times higher than previously reported. Critics blasted the report as 'bogus.'
Reuters
6 minutes ago
- Reuters
Trump weighs taking stake in Intel, Bloomberg News reports
Aug 14 (Reuters) - The Trump administration is in talks with Intel (INTC.O), opens new tab to have the U.S. government potentially take a stake in the struggling chipmaker, Bloomberg News reported on Thursday, citing people familiar with the plan. Such a move would mark another intervention by U.S. President Donald Trump in industries seen as vital to national security. Trump has pushed for multibillion-dollar government tie-ups in semiconductors and rare earths - for instance, a pay-for-play deal with Nvidia (NVDA.O), opens new tab and an arrangement with rare-earth producer MP Materials to secure critical minerals. Intel declined to comment on the report but said it was deeply committed to supporting Trump's efforts to strengthen U.S. technology and manufacturing leadership. White House spokesman Kush Desai said: "Discussion about hypothetical deals should be regarded as speculation unless officially announced by the administration." Intel's shares surged over 7% in regular trading and then another 2.6% after the bell. The discussions follow a meeting this week between Trump and Intel CEO Lip-Bu Tan. That meeting came days after Trump publicly demanded that Tan resign over his investments in Chinese tech companies, some linked to the Chinese military. Details of the stake and price are still being discussed, Bloomberg said. Ryuta Makino, an analyst at Intel investor Gabelli Funds, said it was likely that the U.S. government would take a stake in Intel because Trump wants the chipmaker to expand domestic manufacturing and to create more jobs. Intel warned last month that it may have to get out of the chip manufacturing business if it does not land external customers to make chips in its factories. It planned to slow construction work on new factories in Ohio. Tan, who took the top job just over six months back, has been tasked to undo years of missteps that left Intel struggling to make inroads in the booming AI chip industry dominated by Nvidia, while investment-heavy contract manufacturing ambitions led to heavy losses. "I think any deal that involves the U.S., as well as third-party investors (PE) likely has to come with tariffs that strongly encourage customers like Nvidia, AMD (AMD.O), opens new tab, Apple (AAPL.O), opens new tab to use Intel Foundry," said Ben Bajarin, CEO of market analysis firm Creative Strategies. It is not unusual for the U.S. government to take a stake in a company, but those have usually needed financial help. Though Intel's stock market value has tumbled in recent years and it has lost its industry leadership, its revenue remains stable at over $50 billion a year, and it was not clear to some investors that the chipmaker needs such direct government assistance.
Reuters
6 minutes ago
- Reuters
Wealth Express Launches Transparent Life Insurance Solution to Combat Digital Pricing Deception
ST. PETERSBURG, FL, August 14, 2025 (EZ Newswire) -- Wealth Express, opens new tab, a consumer-first financial solutions platform committed to providing transparency and trust in financial services, today announced the launch of its latest solution: Wealth Express Term Life Insurance with Guaranteed Pricing, opens new tab. This new offering was created to restore confidence for families who have experienced deceptive digital pricing practices, such as bait-and-switch life insurance quotes. Fixing the Trust Gap in Digital Life Insurance With the rise of algorithm-driven life insurance platforms, many families are lured in by attractively low quotes — only to be approved at rates nearly double the original estimate. This "bait-and-switch" model, often marketed as digital convenience, leaves many feeling misled and unprotected. Wealth Express's new life insurance solution offers: 'Families shouldn't be forced to choose between fair pricing and convenience,' said Rob Graham, co-founder of Wealth Express. 'Our life insurance solution removes the guesswork, eliminates surprise price hikes and puts a human advisor back into the equation — because financial protection should build trust, not erode it.' The solution is specifically designed for working parents aged 35 to 50 who want to protect their families without being taken advantage of by hidden fees, digital bait-and-switch tactics or inflated 'convenience' markups. No More "Convenience Tax" According to internal research, many digital platforms charge up to 50% more for the same level of life insurance coverage, simply because they bypass traditional exams. Wealth Express offers the same ease — without the hidden premium. Families know exactly what they'll pay, before they ever commit. Implementation is available immediately through Wealth Express's online platform and licensed advisor network, who work directly with clients to determine the right level of coverage at a rate that doesn't change behind the scenes. About Wealth Express Wealth Express® connects individuals and families with licensed, independent financial professionals who specialize in transparent, principal-protected financial solutions. Whether securing affordable life insurance, building guaranteed retirement income or preserving generational wealth, Wealth Express helps Americans access the tools, advisors and clarity they need to plan with confidence. Built for hardworking Americans, Wealth Express believes wealth is more than money — it's peace of mind, clarity and the assurance that the future is secure. By meeting people where they are and delivering zero-risk, advisor-supported solutions, the company makes real, achievable wealth possible for everyday families. Through its nationwide network of independent certified financial advisors, Wealth Express offers top products from leading carriers, prioritizing protection over volatility and empowerment over confusion. From life insurance to retirement income planning, Wealth Express is committed to making life's biggest financial decisions simpler, safer and smarter. That's Wealth That Works.™ Learn more at opens new tab. Media Contact Richard Lorenzenrlorenzen@ ### SOURCE: Wealth Express Copyright 2025 EZ Newswire See release on EZ Newswire
